Wearable Technology and How This Can Be Implemented into Clinical Practice

Abstract

Purpose of Review Our day-today life is saturated with health data that was previously out of reach. Over the last decade, new devices and fitness technology companies are attempting to tap into this data, uncovering a treasure trove of useful information that, when applied correctly, has the potential to revolutionize the way we approach healthcare and chronic conditions like asthma, especially in the wake of the COVID-19 pandemic. Recent Findings By harnessing exciting developments in personalization, digitization, wellness, and patient engagement, care providers can improve health outcomes for our patients in a way we have never been able to do in the past. While new technologies to capture individual health metrics are everywhere, how can we use this information to make a real difference in our patients' lives? Navigating the complicated landscape of personal wearable devices, asthma inhaler sensors, and exercise apps can be daunting to even the most tech savvy physician. Summary This manuscript will give you the tools necessary to make lasting changes in your patients' lives by exposing them to a world of usable, affordable, and relatable health technology that resonates with their personal fitness and wellness goals. These tools will be even more important post-COVID-19, as the landscape of clinical outpatient care changes from mainly in-person visits to a greater reliance on telemedicine and remote monitoring. Keywords Telemedicine. Wearable devices. Personalized healthcare devices. Remote monitoring. COVID-19. Connected health This article is part of the Topical Collection on Telemedicine and Technology

Sleep Disordered Breathing Diagnosis and Treatment During the COVID-19 Pandemic: A Nationwide Survey in China

“…Telemedicine in China is only in the primary stage, and relevant policies and regulations at the national level are lacking. Unlike medical systems in some other countries, which had very quick responses to expand the coverage for telemedicine services, 23 the number of sleep centers providing this service did not increase significantly during the outbreak. Further studies need to track the outcomes of this new service and explore the suitable subsets of patients and appropriate policies that fit in different medical systems.…”

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

“…Many of these technologies are also being explored for various scenarios in cardiology (44)(45)(46)(47)(48)(49)(50)(51), and have great clinical utility for cardio-oncology and COVID-19. Remote monitoring from wearable biosensors and mHealth is being investigated to improve outcomes in heart rhythm and heart failure and other cardiovascular conditions (44,(46)(47)(48)(49)(50), and may have utility for COVID-19 (19,(52)(53)(54)(55)(56)(57)(58) and Cardio-Oncology (59)(60)(61). Voice apps and voice analysis have shown promise in cardiology for heart failure, ischemic heart disease, pulmonary hypertension, and other forms of cardiovascular disease (45,(62)(63)(64), as well as cardio-oncology (65), and have been considered for COVID-19.…”

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge

“…In the current scenario, extensive awareness of in-depth education about SARS-CoV-2, SARS-CoV and MERS-CoV and multi-directional care between healthcare professionals and hospitalized patients infected with the above-mentioned viruses can help reduce the spread of these viruses [28] , [29] , [30] . It is therefore necessary to have an adequate knowledge of its reservoir, its distribution method and the best accessible management as well as preventive measures [31] , [32] , [33] . Closer monitoring and awareness remain a primary concern for doctors as well as health officials alike [34] , [35] .…”

“…Traditionally, real-time reverse transcription-polymerase chain reaction (RT-PCR) is the most extensively employed diagnostic tool for diagnosing viral infection caused by SARS-CoV-2, SARS-CoV and MERS-CoV, while viral cultures are not approved [27] , [28] , [29] , [30] . In addition, the viral infection can be identified from a combined effect of symptoms, health issues and a chest computed tomography (CT) scan displaying the characteristics of pneumonia [32] , [33] , [34] , [35] . In this article we have reviewed the literature on various aspects, including the history and diversity of SARS-CoV-2, SARS-CoV and MERS-CoV, their detection methods in effective clinical diagnosis (see Scheme 1 ), diagnostic challenges, safety guidelines recommended by World Health Organization (WHO) and legal regulations.…”